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or expression, of conditional cued fear in rats
Fulian Huang1†, Zehua Yang2†, Xiaoyan Liu2 and Chang-Qi Li1*Abstract
Background: Previous studies have shown that melatonin is involved in the processes that contribute to learning
and memory. At present study, we tested the effects of exogenous melatonin (2.5 mg/kg) on the acquisition,
expression and extinction of cued fear in rats.
Results: Results showed that a single afternoon administration 30 min before conditioning has no effect on the
acquisition of cued fear. Compared to rats injected with vehicle, rats injected with melatonin 30 min before
extinction training presented a significant lower freezing during both extinction training and extinction test phases,
however, freezing response did not differ for the initial four trials during extinction training. Melatonin injected
immediately after extinction training was ineffective on extinction learning.
Conclusions: These results suggest that melatonin, at the dose applied in this study, facilitates the extinction of
conditional cued fear without affecting its acquisition or expression, and melatonin facilitates cued fear extinction
only when it is present during extinction training. These findings extend previous research on the melatonin effects
on learning and memory and suggest that melatonin may serve as an agent for the treatment of anxiety disorders
such as posttraumatic stress disorder (PTSD).
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Melatonin is a pineal gland hormone synthesized and
secreted at night in vertebrates. Besides its moderator
role in the regulation of circadian rhythms and sleep [1-3],
melatonin has shown to display antidepressant and anxio-
lytic properties in animal models [4-6]. Moreover, it is
thought to be involved in modulating complex processes
such as learning and memory [7] by binding to receptors
[MT(1)/MT(2)] which are widely distributed in the
brain [8]. For instance, melatonin was shown to possess
memory facilitating effects in the novel object recognition
task [9,10] and the olfactory social memory test in rats
[11]. Other reports showed that melatonin enhances per-
formance in a verbal association task [12] and improves
memory acquisition under stress [13]. And mice lacking
melatonin MT2 receptors showed impaired performance* Correspondence: changqili@csu.edu.cn
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unless otherwise stated.tested in an elevated plus-maze [14]. However, there were
also the opposite outcomes. It was reported that zebrafish
has a better memory performance during the day than
during the night and melatonin is necessary for the sup-
pression of memory during the night [15]. Karakas et al.
[16] injected locally melatonin to the amygdala and found
that such treatment impaired spatial memory performance
of the rats. In addition, we have recently demonstrated
that melatonin impairs the acquisition of contextual fear
memory [17].
To study the involvement of melatonin in memory
processing, we tested the role of melatonin in fear condi-
tioning and fear extinction. Pavlovian fear conditioning in-
volves pairing an initially neutral conditioned stimulus (CS)
such as a tone or context with an aversive unconditioned
stimulus (US) like a footshock. After several pairings of
these stimuli, the CS comes to elicit conditional fear
responses such as defensive behavioral responses (e.g.,
freezing). Considerable evidence suggests that the amyg-
dala is an important site of the neural circuits related to
both cued and contextual fear conditioning. However, the
hippocampus is usually required only for contextual taskLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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CS in the absence of the US results in a progressive re-
duction of the conditioned response. This process is
called extinction. Numerous studies have suggested
that extinction is a form of new, context-dependent
learning [20,21]. These studies suggest that the memory
formed during conditioning is not eliminated during
extinction but rather is suppressed by extinction learning,
which likely attribute to plasticity at distinct synapses from
those mediating acquisition. Converging evidence has
identified a network of brain structures including the
amygdala, prefrontal cortex, and hippocampus [22-25] that
supports the acquisition, storage, retrieval, and contextual
modulation of fear extinction.
As melatonin has been implicated in the acquisition of
contextual fear conditioning [17], it is of particular interest
to examine whether melatonin is involved in regulation of
some aspect of conditional cued fear. Thus, the present
study was designed to assess the effects of systemic in-
jections of melatonin with good penetration through the
blood–brain barrier on the acquisition, expression, and
extinction of conditional cued fear in rats.
Methods
Subjects
Experimental procedures were performed on adult male
Sprague–Dawley rats (270–320 g) obtained from the
Laboratory Animal Center of Central South University,
Changsha, Hunan, China. After arrival, the rats were
housed one per cage at 25°C and an appropriate level
of humidity, with ad libitum access to food and water.
A 12:12 light–dark cycle was maintained, with all pro-
cedures occurred between 3:00 PM. and 6:00 PM. Prior
to all behavioral procedures, the rats were handled
daily for 1 week in order to eliminate handling stress as a
confounding variable. Experiments were conducted ac-
cording to the National Institutes of Health Guide for the
Care and Use of Laboratory Animals, and experimental
protocols were approved by the animal care and use com-
mittee of Central South University.
Behavioral apparatus
Rats underwent fear conditioning and fear extinction in
two different observation chambers (Huaibei Zhenghua
Biological Equipment Co. Ltd., Anhui, China). The cham-
bers (46 cm× 46 cm× 46 cm, without ceiling) were situated
within a sound-attenuating cabinet individually. On the
ceiling of the cabinet was a speaker to present acoustic CSs
and a 8 W white house light to illuminate the chamber. A
ventilation fan mounted on the right wall of the cabinet
provided a 60 dB background noise and air exchange. For
fear conditioning, the walls of the chamber (context A)
were made of black opaque Plexiglas. The floor of context
A consisted of 23 stainless steel bars (6 mm in diameter)spaced 20 mm apart that were connected to a shock gener-
ator and scrambler for the delivery of foot-shock USs. The
presentation and sequencing of all stimuli was controlled
by a custom written computer program. The chamber was
thoroughly cleaned with water and dried between sessions.
For extinction training and CS testing, rats were placed in
a novel chamber (context B) with transparent Plexiglas
walls and a smooth black plastic floor to minimize
generalization to the conditioning chamber. The chamber
was cleaned with 75% ethanol before each session.Cued fear acquisition
Experiment 1 investigating the effects of melatonin on the
acquisition of cued fear (Figure 1A) involved three phases:
habituation (context A), fear conditioning (context A) and
testing (context B), each separated by 24 h to allow for
memory consolidation. During habituation phase (Day 0),
rats were habituated to the conditioning chamber (context
A) for 20 min with no stimuli presented. On day 1 (fear
conditioning phase), rats were allowed to explore the
chamber for 3 min. At the end of 3 min rats were sub-
jected to five trials of audio tone (CS) and foot shock (US)
with an inter-trial interval of 60 sec. Audio tone (4 kHz,
80 dB, 20 sec duration) was followed immediately by a
footshock (0.5 mA, 0.5 sec duration) from the metal grid
floor. The rats remained in the training box for 60 s fol-
lowing the last CS-US pairing, after which they were
returned to the home cages. On Day 2 (testing phase),
after a 3 min acclimation, rats received 5 tone alone pre-
sentations with an inter-trial interval of 60 sec.Cued fear extinction
Experiment 2 and Experiment 3 investigating the effects
of melatonin on cued fear extinction (Figure 2A) involved
four phases: habituation (context A), fear conditioning
(context A), extinction training (context B) and extinction
test (context B), each separated by 24 h to allow for
memory consolidation. In both experiments, cued fear
was induced in nondrugged, naı¨ve rats described above.
On Day 0 (habituation phase) and Day 1 (fear condition-
ing phase), the habituation and fear conditioning trainings
were same as described in Experiment 1. Rats were
matched into two groups that received either melatonin
or vehicle based on freezing during the third training
CS. Twenty-four hours after fear conditioning (Day 2,
extinction training phase), rats were placed in context B
and were allowed to acclimate for 3 min. Following this,
rats received 14 tone (4 kHz, 80 dB, 20 sec duration)
alone presentations with an inter-trial interval of 60 sec.
The rats were immediately returned to their home cages
60 s after the last tone presentation. On day 3 (extinction
test phase), rats received 14 tone alone presentations in
context B as described on day 2.
Figure 1 Melatonin does not affect cued fear acquisition. (A) Schematic of the behavioral procedure used. Behavior procedure involved
three training phases: habituation, fear conditioning and test. Rats were administrated melatonin 30 min before conditioning phase. (B) Percent
freezing during the five cues was shown for the melatonin group (n = 10) and the vehicle group (n = 10) during conditioning phase. (C) Percent
freezing to the five cues during test phase. Mel = melatonin group, Veh = vehicle group. All data are represented as mean ± SEM.
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Melatonin was purchased from Sigma-Aldrich and was
tested at doses of 2.5 mg/kg. This compound was dis-
solved in small volume of 75% ethanol and further diluted
in saline (vehicle) to the final volume immediately
before administration. The final concentration of alcohol
was <0.5%. Rats were administered intraperitoneally (i.p.)
in a volume of 5 ml/kg body weight. Vehicle-treated rats
received the same volume via i.p. injection.
Timing of melatonin injection
Rats were given i.p. injections of melatonin (2.5 mg/kg) or
vehicle 30 min before fear conditioning in Experiment 1
(Figure 1A), 30 min before extinction training in Ex-
periment 2 (Figure 2A) or immediately after extinction
training in Experiment 3 (Figure 3A).
Statistical analyses
Freezing was used as the measure of conditional fear re-
sponse during fear conditioning phase, extinction training
phase and testing phase. Freezing is characterized by ces-
sation of movement except that required for respiration
(Blanchard and Blanchard, 1969). The total time spent
freezing during every 20-s tone CS was scored offline with
a digital stopwatch from digital videos. Observers scoring
freezing were blind to the treatments. Freezing is presented
as the percent time spent freezing (time spent freezing/total
time × 100). Total session means were analyzed with Stu-
dent’s t-test. Multiple trial data were analyzed with two-way
repeated-measures analysis of variance (ANOVA). Post-hoc
comparisons were performed with the Tukey HSD method.
All data were represented as mean ± SEM. Significant levelwas set at p < 0.05. Statistics were run on SPSS (Version 13;
SPSS, Chicago, IL).
Results
Experiment 1: Effects of melatonin on the acquisition or
retention of conditional cued fear
First, we investigated the effects of melatonin on cued fear
acquisition. We injected melatonin 30 min before fear
conditioning. During the conditioning phase (Figure 1B),
the melatonin and vehicle groups presented a progressive
increase in the conditioned fear response across trials. A
two-way repeated-measures ANOVA of percent freezing
found there was a significant effect of trial (F (4, 72) =
278.343, p < 0.001) but not group (F (1, 18) = 0.010,
p > 0.05) or interaction of group and tone block (F (4, 72) =
2.876, p > 0.05), indicating that the two groups showed
equivalent fear learning. At 24 h post-conditioning, the
rats were presented with the CS in a novel context.
There was no a significant group effect of percent freezing
(p > 0.05) (Figure 1C). These data suggest that melatonin
does not affect the acquisition and retention of cued fear.
Experiment 2: Effects of pre-extinction melatonin on
extinction and expression of conditional cued fear
Next, we assessed the effects of melatonin on the expres-
sion and extinction of cued fear memory. Two groups of
naı¨ve rats underwent fear conditioning. One day after
training, rats were injected with melatonin or vehicle
30 min before extinction training. The next day, they were
subjected to a drug-free extinction test.
During the extinction training phase, a significantly
lower freezing was observed in the melatonin group in
Figure 3 Melatonin injected immediately after extinction training has no effect on extinction learning. (A) Schematic of the behavioral
procedure used. Behavior procedure involved four training phases: habituation, fear conditioning, extinction training and extinction test. Rats
were administrated melatonin immediately after extinction training. (B) Percent freezing to the CSs was shown for the melatonin group (n = 6)
and the vehicle group (n = 6) during extinction training. (C) Percent freezing to the CSs during extinction testing. Mel = melatonin group,
Veh = vehicle group. All data are represented as mean ± SEM.
Figure 2 Melatonin facilitates extinction, but not expression, of cued fear. (A) Schematic of the behavioral procedure used. Behavior
procedure involved four training phases: habituation, fear conditioning, extinction training and extinction test. Rats were administrated melatonin
30 min before extinction training. (B) Percent freezing to the CSs, averaging across all trials, was shown for the melatonin group (n = 10) and the
vehicle group (n = 10) during extinction training. (C) Percent freezing to the CSs, averaging across all trials during extinction testing. (D) Reduction in
percent freezing between the extinction training and extinction test based on the data in B and C. (E) Percent freezing to the CSs during extinction
training. Freezing was also scored during a 3 min acclimation period (Pre-CS). (F) Percent freezing to the CSs during extinction testing. Data used in
B and C were reanalyzed for the trials of percent freezing. Mel =melatonin group, Veh = vehicle group. ** P < 0.01 for comparisons between the
melatonin group and the vehicle group. All data are represented as mean ± SEM.
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During the extinction test phase, level of freezing was
significantly lower in both groups when compared with
the respective level measured during extinction training
(p < 0.001) (Figure 2C), indicating successful retrieval of
extinction learning. A significant difference in the level of
freezing between the two groups was observed during ex-
tinction testing (p < 0.001) (Figure 2C). Moreover, in the
melatonin group, the reduction in the levels of freezing
from extinction training to extinction testing was signifi-
cant compared to the vehicle group (p < 0.001) (Figure 2D).
These results suggest that injection of melatonin 30 min
before the extinction training facilitates the acquisition
and retention of extinction learning.
The data were reanalyzed for the trials of percent
freezing using two-way repeated-measures ANOVA.
During extinction training, the two groups presented a
gradual reduction in freezing across trials (trial, F (13,
234) = 83.843, p < 0.001) (Figure 2E). The melatonin group
showed a significant decrease in the level of freezing
compared to the vehicle group (group, F (1, 18) = 749.594,
p < 0.001; group × trial, F (13, 234) = 28.065, P < 0.001).
Post hoc comparisons indicated that rats injected with
melatonin or vehicle expressed similar freezing response
during the initial four trials (all, P > 0.05) (Figure 2E).
However, the melatonin group presented a significant
lower freezing in the other trials (all, P < 0.001) (Figure 2E).
In contrast, during extinction test phase, the level of freez-
ing response for the melatonin group was significantly
lower at each trial compared with the vehicle group
(p < 0.001 for all trials) (Figure 2F). These results suggest
that melatonin injection doesn’t affect the expression of
conditional fear.
To confirm that confounding effects of nonspecific
freezing responses to context itself were not somehow
influencing freezing responses, we also recorded the
time spent freezing during the 3 min pre-CS period of
extinction training on day 3 in context B. There was no
significant difference in the level of freezing between the
melatonin group and vehicle group (P > 0.05) (Figure 2E),
suggesting that melatonin does not significantly affect
unconditioned freezing responses to the chamber alone.
Experiment 3: Effects of post-extinction melatonin on
extinction of conditional cued fear
We also administered melatonin immediately after ex-
tinction training to determine the effects of melatonin
on extinction when it is administrated at different time
points.
During the extinction training phase (Figure 3B), the
level of freezing by rats in the melatonin and vehicle
groups decreased across trials (F (13, 130) = 46.553,
p < 0.001). There was no a significant effect of group
(F (1, 10) = 0.411, p > 0.05) and no significant trial-by-groupinteraction (F (13, 130) = 2.254, p > 0.05). During the extinc-
tion test session (Figure 3C), both groups also presented
a progressive decrease in freezing responses across trials
(F (13, 130) =93.234, p < 0.001). There was no a significant
effect of group (F (1, 10) = 0.049, p > 0.05) and no sig-
nificant trial-by-group interaction (F (13, 130) = 1.566,
p > 0.05). These results suggest that melatonin administra-
tion immediately after extinction training has no effect on
the extinction of conditional cued fear.
Discussion
We presented data that suggest a differential effect of
melatonin on acquisition and extinction of conditional
fear in rats. For cued fear, melatonin (2.5 mg/kg) following
a single i.p. administration had no effect on the acquisition
and retention of conditional cued fear response in rats
(Figure 1). This was indicated by the observation that the
melatonin and vehicle groups showed an identical increase
of freezing with training trials during the conditioning
phase on Day 1 and an identical great conditional fear
during drug-free testing phase on Day 2.
On the other hand, pre-extinction injection of mela-
tonin facilitated the acquisition and retention of cued fear
extinction (Figure 2). These effects could not be attributed
to changes of nonspecific responses to context itself that
followed melatonin injection (Figure 2E). In addition, aug-
mented locomotion or anxiolytic property of melatonin
may be indirect factors that attenuate freezing behavior.
However, our previous study [17] showed that melatonin
injection with the same dose as used in the present study
did not induce significant difference in spontaneous
locomotor activity or anxiety behavior as assessed with
the open field test. Thus, facilitation of extinction learn-
ing by melatonin could not be attributed to stimulated
locomotion or altered anxiety behavior. Further, initial
freezing levels during extinction training were similar
for melatonin- and vehicle-treated rats (Figure 2E).
These results argue that melatonin has no interference
with the expression of cued conditional fear, which also
confirms further its effect on fear extinction. Collectively,
although there were no effects on the acquisition or
expression of cued fear, melatonin facilitated cued fear
extinction. This finding that melatonin exerts opposing
influences on the acquisition and extinction of conditional
fear is in accordance with many other studies showing
that acquisition and extinction are distinct learning pro-
cesses. There exists behavioral, systems, and molecular
differences between acquisition and extinction [21,26-28].
Furthermore, in line with the present finding, it has
been found that melatonin facilitates the extinction of
active avoidance reflex, whereas memory acquisition is
not influenced [29].
In contrast with the ability of pre-extinction injection of
melatonin to facilitate the extinction, a post-extinction
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Therefore, these results suggest that melatonin facilitates
cued fear extinction only when it is present during extinc-
tion training. This finding is in accordance with a previous
study [15]. In this study, using a modified active-avoidance
conditioning (AAC) paradigm, melatonin applied before
training significantly suppressed long-term memory for-
mation in zebrafish, however, no effect of melatonin on
long-term memory formation was observed when it was
given directly after training. These observations, together
with our present results, suggest that melatonin has a pro-
found influence on memory consolidation at a relatively
early stage of long-term memory formation.
We have shown previously that melatonin impairs the
acquisition of contextual fear response [17]. Our findings
and earlier studies that produced contradictory findings
[9,10,13-16,30,31] indicated that melatonin exerts facili-
tating or inhibiting effects on memory in different tasks.
Taken overall, our present and previous results [17] sug-
gest that melatonin exerts effects on the acquisition of
contextual fear and cued fear extinction, but has no
effect on cued fear conditioning. It is well established that
cued fear conditioning is a hippocampus-independent task
[32], while contextual fear conditioning requires the
hippocampus [33-35]. Also, fear extinction is a form of
active learning [20,21]. Studies of the hippocampus have
shown that the hippocampus is involved in the acquisi-
tion and consolidation of cued fear extinction, although
the hippocampus is not essential for the acquisition of
extinction per se [36,37]. In the brain, binding sites of
melatonin have been found in the amygdala, hippocam-
pus and prefrontal cortex [38-40], three regions that are
involved in fear extinction [21,23]. Although we cannot
be sure at which region melatonin acts to modulate ex-
tinction, these evidences suggest that the hippocampus
may be the relevant sites.
Although the mechanisms through which melatonin
acts on extinction remains to be determined, melatonin
may have an indirect effect on memory formation via
some neurotrophin such as brain derived neurotrophic
factor (BDNF). Melatonin has been shown to increase
the production of BDNF [41] that may play an important
role in cued fear extinction [36]. Further, melatonin
modulates neurotransmitters such as gama amino bu-
tyric acid (GABA) [42] and glutamate [43] which are
involved in extinction learning [44]. Alternatively, the
effects of melatonin may be through the direct modulation
of memory formation circuits. Melatonin has shown to
play an important role in structural remodeling of synaptic
connections during memory and learning processes [45].
Other researches also demonstrated the ability of melatonin
to modulate neuronal firing in the hippocampus and other
brain regions [46,47]. Further, a previous research showed
that MT(2) receptor knockout mice demonstrates asignificantly reduced long-term potentiation (LTP) as well
as impaired memory performance tested in an elevated
plus-maze paradigm [14]. Thus, melatonin may regulate
learning and memory through its influence on synaptic
connections in central nervous system neurons. Despite
these evidences, the mechanism why Melatonin facilitates
just extinction in our researches is still not known and
there is at least one explanation. It was demonstrated that
melatonin’s action on hippocampal LTP was mediated via
the MT(2) melatonin receptor subtype through the regu-
lation of adenylyl cyclase–protein kinase A (AC–PKA)
pathway [47]. This pathway is critical for the formation of
fear memory [48-50], but may be constraint for the extinc-
tion of fear because increased PKA activity impaired fear
extinction [51,52] whereas reduction of PKA activity facili-
tated fear extinction [50]. As melatonin inhibits activity of
AC [53] and PKA [47], extinction of conditioned fear may
be facilitated by melatonin through a mechanism involv-
ing regulation of the AC–PKA pathway. It is interesting to
test this possibility in future research.
There has been an available effective means of
extinction-based exposure psychotherapy for the treat-
ment of anxiety disorders, such as PTSD [54,55] which
has been hypothesized to result from impaired extinc-
tion of fear memory [56,57]. Furthermore, decreased
melatonin levels in patients with PTSD were reported
in clinical studies [58]. Therefore, facilitating effects of
melatonin on fear extinction suggest that melatonin may
serve as an agent for the treatment of anxiety disorders
such as PTSD.
Conclusion
In conclusion, the present observations demonstrate that
intraperitoneal administration of melatonin (2.5 mg/kg)
facilitated the extinction of conditional cued fear without
affecting its acquisition or expression, and melatonin facil-
itated cued fear extinction only when it is present during
extinction training. Additional studies will be required to
specify the brain regions that mediate the extinction effects
of melatonin as well as to explore mechanism through
which melatonin exerts its effects on extinction learning.
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